-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Sophia Genetics, Raises Price Target to $7

Benzinga·01/26/2026 16:39:13
Listen to the news
Guggenheim analyst Subbu Nambi maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $6 to $7.